Abstract
In vitro determination of 3H-thymidine labeling index (LI%) was carried out in craniopharyngiomas from 16 patients submitted to repeated surgical procedures. This study showed a poor correlation between LI% values and prognosis, but allowed to detect a high LI% variation in the same tumor investigated in serial different times. The spatial distribution of S-phase proliferative cells in squamous epithelium of cystic components suggests a rationale for intracavitary treatment of cystic and mixed craniopharyngioma and may help explain its success.
MeSH terms
-
Adolescent
-
Adult
-
Bleomycin / administration & dosage
-
Cell Division / drug effects
-
Cell Division / physiology*
-
Cell Division / radiation effects
-
Chemotherapy, Adjuvant
-
Child
-
Child, Preschool
-
Combined Modality Therapy
-
Craniopharyngioma / drug therapy
-
Craniopharyngioma / pathology*
-
Craniopharyngioma / radiotherapy
-
Craniopharyngioma / surgery
-
Female
-
Humans
-
Injections, Intralesional
-
Male
-
Middle Aged
-
Neoplasm Recurrence, Local / drug therapy
-
Neoplasm Recurrence, Local / pathology
-
Neoplasm Recurrence, Local / radiotherapy
-
Neoplasm Recurrence, Local / surgery
-
Pituitary Gland / drug effects
-
Pituitary Gland / pathology
-
Pituitary Irradiation
-
Pituitary Neoplasms / drug therapy
-
Pituitary Neoplasms / pathology*
-
Pituitary Neoplasms / radiotherapy
-
Pituitary Neoplasms / surgery
-
Radiotherapy, Adjuvant
-
Stereotaxic Techniques
-
Treatment Outcome